|
Time Course of Markers of Oxidative Stress for the CoQ10 and Placebo (CON) subjects taken immediately after each performance test. |
|||||
| Variable |
Time |
CoQ10 |
Placebo |
Significance |
|
|
|
|||||
| Superoxide Dismutase (SOD) (U/ml) |
Baseline T2 |
1.52 ± 0.31 |
1.59 ± 0.27 |
Group |
0.103 |
| Isokinetic T2 |
1.56 ± 0.24 |
1.80 ± 0.39 |
Time |
0.001 |
|
| Wingate T2 |
1.75 ± 0.23 |
1.70 ± 0.22 |
G × T |
0.060 |
|
| GXT T2 |
1.68 ± 0.17 |
1.70 ± 0.26 |
|||
| Baseline T3 |
1.61 ± 0.40 |
1.77 ± 0.52 |
Group |
0.296 |
|
| Isokinetic T3 |
1.74 ± 0.37 |
1.90 ± 0.54 |
Time |
0.001† |
|
| Wingate T3 |
1.91 ± 0.39 |
2.06 ± 0.51 |
G × T |
0.966 |
|
| GXT T3 |
1.81 ± 0.42 |
1.98 ± 0.50 |
|||
| Thiobarbituric Acid Reactive Substance (TBARS) (μM) |
Baseline T2 |
2.79 ± 1.02 |
2.50 ± 1.34 |
Group |
0.042 |
| Isokinetic T2 |
4.11 ± 1.71 |
3.24 ± 1.69 |
Time |
0.001 |
|
| Wingate T2 |
4.72 ± 2.14 |
3.35 ± 1.57† |
G × T |
0.018† |
|
| GXT T2 |
5.09 ± 2.23 |
3.62 ± 1.90† |
|||
| Baseline T3 |
3.03 ± 1.03 |
3.12 ± 1.26 |
Group |
0.540 |
|
| Isokinetic T3 |
4.28 ± 1.72 |
4.23 ± 1.47 |
Time |
0.001 |
|
| Wingate T3 |
4.25 ± 1.17 |
4.85 ± 2.11 |
G × T |
0.534 |
|
| GXT T3 |
5.32 ± 2.09 |
5.52 ± 1.89 |
|||
| 8-Isoprostane (pg/ml) |
Baseline T2 |
76 ± 28 |
78 ± 33 |
Group |
0.616 |
| Isokinetic T2 |
86 ± 63 |
88 ± 61 |
Time |
0.050 |
|
| Wingate T2 |
105 ± 72 |
99 ± 63 |
G × T |
0.431 |
|
| GXT T2 |
108 ± 67 |
110 ± 62 |
|||
| Baseline T3 |
84 ± 46 |
79 ± 35 |
Group |
0.334 |
|
| Isokinetic T3 |
101 ± 37 |
124 ± 75 |
Time |
0.001 |
|
| Wingate T3 |
114 ± 53 |
122 ± 69 |
G × T |
0.553 |
|
| GXT T3 |
99 ± 49 |
111 ± 87 |
|||
|
Data are means and ± standard deviations of mean. † represents p < 0.05 difference between groups | |||||
Cooke et al. Journal of the International Society of Sports Nutrition 2008 5:8 doi:10.1186/1550-2783-5-8 |
|||||